#Zafgen
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr posted its first advertisements in May 2012 and subsequently earned $13M in revenue.
Text
Craniopharyngioma Pipeline, Clinical Trials, and Companies – Novartis, Blaze Bioscience, Bristol Myers Squibb, INSYS Therapeutics, Zafgen
http://dlvr.it/SrqtVr
0 notes
Text
Craniopharyngioma Pipeline, Clinical Trials, and Key Companies|Companies – Novartis, Blaze Bioscience, Bristol Myers Squibb, INSYS Therapeutics, Zafgen
http://dlvr.it/SqkZDl
0 notes
Text
ACLIMOSTAT
Aclimostat CAS: 2082752-83-6 Chemical Formula: C26H42N2O6 Molecular Weight: 478.63 Elemental Analysis: C, 65.25; H, 8.85; N, 5.85; O, 20.06
ZGN-1061; ZGN1061; ZGN 1061; Aclimostat,
UNII-X150A3JK8R
X150A3JK8R
(3R,4S,5S,6R)-5-Methoxy-4-[(2R,3R)-2-methyl-3-(3- methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl 3-[2-(morpholin-4-yl)ethyl]azetidine-1-carboxylate
1-Azetidinecarboxylic acid,…
View On WordPress
0 notes
Link
0 notes
Text
Aurora Cannabis (NYSE:ACB), Zafgen (NASDAQ:ZFGN), and Overstock.com (NASDAQ:OSTK) were among the worst performers on the day. Read More...
1 note
·
View note
Text
Polycystic Ovary Syndrome Market by Roots Analysis
Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors
London
Roots Analysis has announced the addition of “Polycystic Ovary Syndrome Market, 2021-2031” report to its list of offerings.
Currently, there is no cure for polycystic ovary syndrome (PCOS / PCOD), however the affiliated symptoms can be treated using a combination of different types of medications, including insulin-sensitizing agents, oral contraceptives, anti-androgens and anti-obesity drugs. The research activities, including clinical investigations in this domain are being driven by both industry and non-industry players.
To order this 90+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html
Key Market Insights
Currently, more than 60 drugs are marketed / under development for PCOS
More than 80% of the drugs in the market are designed for symptomatic treatment of PCOS whilst a few drugs are being evaluated for curing this clinical condition. Among various types of drugs available, hormonal contraceptives and insulin sensitizing agents are used for the first line treatment. Popular hormonal contraceptives include Beyaz®, Clomid®, Diane 35® and Yasmin®.
More than 40 industry and non-industry players are engaged in the development of drugs for PCOS
Majority of the industry players (70%) are very large firms (having more than 500 employees). North America is the current hub, where close to 45% players are based. This is followed by Europe (28%), Asia-Pacific (9%), and Middle East and North Africa (7%).
Around 700 clinical trials are currently evaluating the therapeutics effects of drugs for PCOS, worldwide
It is worth mentioning that more than 50% of the trials were / are being conducted in Europe and Asia-Pacific region; however, more than 80% of the patients are enrolled in clinical trials being conducted in North America. Further, 86% of the total trials are being sponsored by non-industry players.
More than 400 grants have been awarded to support research on drugs for PCOS, since 2016
An estimated USD 168.2 million in grants have been awarded to various companies / organizations working in this domain during the time period between 2016 -April 2021. Almost 60% of the total grant amount was funded by the National Institute of Child Health and Human Development.
Around 60 eminent scientists (identified as key opinion leaders (KOLs)) are involved in the clinical trials of drugs for PCOS
More than 30% of these KOLs are associated with the organizations based in Asia-Pacific, followed by those in Middle East and North Africa (28%), North America (22%) and Europe (17%). Majority of these KOLs are currently affiliated to schools and universities.
Close to 3,800 patents have been filed / granted related to PCOS, since 2016
Around 60% of these are patent applications, while rest of the patents have been granted. Further, R&D activity related to PCOS is largely concentrated in the US, where over 50% of the total number of patents were filed. Leading industry players (in terms of the size of intellectual property portfolio) include Bristol Myers Squibb, Genentech, Merck and Zafgen.
The market is anticipated to grow at a CAGR of 4%, during the period 2021-2031
Growth in this domain is anticipated to be driven by the sales of insulin-sensitizing agents that are expected to capture over 45% of the market share by 2031. Further, majority share (83%) of the market is captured by oral drugs
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market/request-sample.html
Key Questions Answered
§ What are the prevalent R&D trends related to PCOS?
§ What are the key challenges faced by stakeholders in this area?
§ Which are the principal therapies being developed for PCOS?
§ Who are the leading industry and non-industry players in this field?
§ What are the contributions of big pharma players in this field?
§ Which are the key geographies where research on polycystic ovarian syndrome is being conducted?
§ Which are the leading administering institute centers supporting the research in this field?
§ How has the intellectual property landscape in this market evolved over the years?
§ Who are the key opinion leaders / experts in this field?
§ What are the factors that are likely to influence the evolution of this market?
§ How is the current and future market opportunity likely to be distributed across key market segments?
The USD 5 billion (by 2031) financial opportunity within the PCOS market has been analyzed across the following segments:
§ Drug Class
§ Insulin Sensitizing Agents
§ Oral Contraceptives
§ Anti-Androgens
§ Anti-Obesity
§ Route of Administration
§ Oral
§ Subcutaneous
§ Intravenous
§ Others
§ Key Geographical Regions
§ North America (US, Canada)
§ Europe (France, Germany, Italy, Spain, UK)
§ Asia-Pacific and Rest of the World (Australia, China, India and Japan)
The research includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), drug portfolio, details on recent developments, as well as an informed future outlook.
§ AbbVie
§ Bayer
§ GlaxoSmithKline
§ Lupin Pharmaceuticals
§ Merck
§ Pfizer
§ Takeda
§ Teva Pharmaceuticals
For additional details, please visit
https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html or email [email protected]
You may also be interested in the following titles:
1. Non-hormonal Therapies for Women’s Health Market, 2021-2030
2. Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
3. Vascular Disrupting Agents Market, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Details
Ben Johnson
+1 (415) 800 3415
Roots Analysis
Web: https://medium.com/@RootsAnalysis
LinkedIn: https://medium.com/@RootsAnalysis
Twitter: https://medium.com/@RootsAnalysis
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
0 notes
Text
Polycystic Ovary Syndrome Market, 2021-2031 by Roots Analysis
Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors
London
Roots Analysis has announced the addition of “Polycystic Ovary Syndrome Market, 2021-2031” report to its list of offerings.
Currently, there is no cure for polycystic ovary syndrome (PCOS / PCOD), however the affiliated symptoms can be treated using a combination of different types of medications, including insulin-sensitizing agents, oral contraceptives, anti-androgens and anti-obesity drugs. The research activities, including clinical investigations in this domain are being driven by both industry and non-industry players.
To order this 90+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html
Key Market Insights
Currently, more than 60 drugs are marketed / under development for PCOS
More than 80% of the drugs in the market are designed for symptomatic treatment of PCOS whilst a few drugs are being evaluated for curing this clinical condition. Among various types of drugs available, hormonal contraceptives and insulin sensitizing agents are used for the first line treatment. Popular hormonal contraceptives include Beyaz®, Clomid®, Diane 35® and Yasmin®.
More than 40 industry and non-industry players are engaged in the development of drugs for PCOS
Majority of the industry players (70%) are very large firms (having more than 500 employees). North America is the current hub, where close to 45% players are based. This is followed by Europe (28%), Asia-Pacific (9%), and Middle East and North Africa (7%).
Around 700 clinical trials are currently evaluating the therapeutics effects of drugs for PCOS, worldwide
It is worth mentioning that more than 50% of the trials were / are being conducted in Europe and Asia-Pacific region; however, more than 80% of the patients are enrolled in clinical trials being conducted in North America. Further, 86% of the total trials are being sponsored by non-industry players.
More than 400 grants have been awarded to support research on drugs for PCOS, since 2016
An estimated USD 168.2 million in grants have been awarded to various companies / organizations working in this domain during the time period between 2016 -April 2021. Almost 60% of the total grant amount was funded by the National Institute of Child Health and Human Development.
Around 60 eminent scientists (identified as key opinion leaders (KOLs)) are involved in the clinical trials of drugs for PCOS
More than 30% of these KOLs are associated with the organizations based in Asia-Pacific, followed by those in Middle East and North Africa (28%), North America (22%) and Europe (17%). Majority of these KOLs are currently affiliated to schools and universities.
Close to 3,800 patents have been filed / granted related to PCOS, since 2016
Around 60% of these are patent applications, while rest of the patents have been granted. Further, R&D activity related to PCOS is largely concentrated in the US, where over 50% of the total number of patents were filed. Leading industry players (in terms of the size of intellectual property portfolio) include Bristol Myers Squibb, Genentech, Merck and Zafgen.
The market is anticipated to grow at a CAGR of 4%, during the period 2021-2031
Growth in this domain is anticipated to be driven by the sales of insulin-sensitizing agents that are expected to capture over 45% of the market share by 2031. Further, majority share (83%) of the market is captured by oral drugs
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market/request-sample.html
Key Questions Answered
§ What are the prevalent R&D trends related to PCOS?
§ What are the key challenges faced by stakeholders in this area?
§ Which are the principal therapies being developed for PCOS?
§ Who are the leading industry and non-industry players in this field?
§ What are the contributions of big pharma players in this field?
§ Which are the key geographies where research on polycystic ovarian syndrome is being conducted?
§ Which are the leading administering institute centers supporting the research in this field?
§ How has the intellectual property landscape in this market evolved over the years?
§ Who are the key opinion leaders / experts in this field?
§ What are the factors that are likely to influence the evolution of this market?
§ How is the current and future market opportunity likely to be distributed across key market segments?
The USD 5 billion (by 2031) financial opportunity within the PCOS market has been analyzed across the following segments:
§ Drug Class
§ Insulin Sensitizing Agents
§ Oral Contraceptives
§ Anti-Androgens
§ Anti-Obesity
§ Route of Administration
§ Oral
§ Subcutaneous
§ Intravenous
§ Others
§ Key Geographical Regions
§ North America (US, Canada)
§ Europe (France, Germany, Italy, Spain, UK)
§ Asia-Pacific and Rest of the World (Australia, China, India and Japan)
The research includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), drug portfolio, details on recent developments, as well as an informed future outlook.
§ AbbVie
§ Bayer
§ GlaxoSmithKline
§ Lupin Pharmaceuticals
§ Merck
§ Pfizer
§ Takeda
§ Teva Pharmaceuticals
For additional details, please visit
https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html or email [email protected]
You may also be interested in the following titles:
1. Non-hormonal Therapies for Women’s Health Market, 2021-2030
2. Squamous Non-Small Cell Lung Cancer: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
3. Vascular Disrupting Agents Market, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Details
Ben Johnson
+1 (415) 800 3415
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
0 notes
Text
Weight Loss and Obesity Management Market : Features, Opportunities and Challenges forecast to 2028
Weight Loss and Obesity Management market research report displays key data and information about several factors which helps achieve success in the competitive marketplace. Summary of the market is analysed with respect to market players who are mainly customers, businesses or clients. SWOT analysis is the standard, prominent and full-proof method to perform the market research study which is used to formulate this particular Weight Loss and Obesity Management market report. To be ahead of the competition, a systematic idea about the competitive landscape, their product range, their strategies, and future prospects are very important. This market document also comprises of key performers, vendors, and suppliers.
The weight loss and obesity management market is expected to witness market growth at a rate of 6.74% in the forecast period of 2021 to 2028 and is expected to reach USD 360.55 million by 2028.
A thorough market study and investigation of trends in consumer and supply chain dynamics covered in this report helps businesses draw the strategies about sales, marketing, and promotion. Besides, market research performed in this Weight Loss and Obesity Management report puts a light on the challenges, market structures, opportunities, driving forces, and competitive landscape for the business. It assists in obtaining an extreme sense of evolving industry movements before competitors. To gain competitive advantage in this swiftly transforming marketplace, opting for such market research report is highly suggested as it gives a lot of benefits for a thriving business.
Get Sample PDF of Weight Loss and Obesity Management Market Report (including COVID19 Impact Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-weight-loss-and-obesity-management-market
Weight Loss and Obesity Management Market Country Level Analysis
The weight loss and obesity management market is analyzed and market size insights and trends are provided by country, diet, equipment and service as referenced above.
The countries covered in the global weight loss and obesity management market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Key Players: Global Weight Loss and Obesity Management Market
Ajinomoto Co.,Inc., Herbalife International of America, Inc., Nestlé SA, PepsiCo, Johnson Health Tech, THE COCA-COLA COMPANY, Nutrisystem, Inc., Mayo Foundation for Medical Education and Research (MFMER), Zafgen, Inc., WW International, Inc., Jenny Craig, Diet Health, Inc., VLCC, 24 Hour Fitness USA, Inc., Life Time, Inc., Abbott, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Atkins Nutritionals, Inc., Brunswick, Kellogg NA Co., Merck & Co., Inc., Reebok International, Unilever, Precor Incorporated, ALLERGAN, Johnson & Johnson Services, Inc., Decathlon, Technogym, Apollo Endosurgery, Inc., Amer Sports, GOLD’S GYM
MAJOR TOC OF THE REPORT
Chapter One: Weight Loss and Obesity Management Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Weight Loss and Obesity Management Market Competition, by Players
Chapter Four: Global Weight Loss and Obesity Management Market Size by Regions
Chapter Five: Global Weight Loss and Obesity Management Market Revenue by Countries
Chapter Six: Global Weight Loss and Obesity Management Market Revenue by Diet
Chapter Seven: Global Weight Loss and Obesity Management Market Revenue by Equipment
Chapter Eight: Global Weight Loss and Obesity Management Market Revenue by Service
Get Detail TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=global-weight-loss-and-obesity-management-market
Key Report Highlights
Comprehensive pricing analysis based on different product types and regional segments
Market size data in terms of revenue and sales volume
Deep insights about regulatory and investment scenarios of the global Weight Loss and Obesity Management Market
Analysis of market effect factors and their impact on the forecast and outlook of the global Weight Loss and Obesity Management Market
The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Weight Loss and Obesity Management Market
A roadmap of growth opportunities available in the Global Weight Loss and Obesity Management Marketwith the identification of key factors
The exhaustive analysis of various trends of the Global Weight Loss and Obesity Management Marketto help identify market developments
Key Questions Answered in Report:
What is the key to the Weight Loss and Obesity Management Market?
What will the Weight Loss and Obesity Management Market Demand and what will be Growth?
What are the latest opportunities for Weight Loss and Obesity Management Market in the future?
What are the strengths of the key players?
Which region accounted for the largest Weight Loss and Obesity Management market share?
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-weight-loss-and-obesity-management-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
Radiology Services Market
Weight Loss and Obesity Management Market
Blood Warmer Devices/Sample Warmer Market
0 notes
Text
Weight Loss Therapeutics Market Share, Analysis, Demand and Forecasts to 2025
The study report offers a comprehensive analysis of Weight Loss Therapeutics Market size across the world as regional and country-level market size analysis, CAGR estimation of market growth during the forecast period, revenue, key players, competitive background, and sales analysis of the payers. alongside that, the report describes the main challenges and risks to face within the forecast period. Weight Loss Therapeutics Market is segmented by Type, and by Application. Players, stakeholders, and other participants within the global Weight Loss Therapeutics Market are going to be ready to gain the whip hand as they use the report as a strong resource.
Discover Who You Really Compete Against In The Marketplace, Get Free PDF Sample Report Now! @ https://www.acquiremarketresearch.com/sample-request/348439/
Additionally, the research report on the global Weight Loss Therapeutics Market provides an in-depth analysis of the market status, market size, revenue share, industry development trends, products’ advantages and drawbacks of the enterprise, industrial policy, and regional industrial layout characteristics. the worldwide Weight Loss Therapeutics Market report covers recent developments, strategic market growth analysis, area marketplace expanding, product launches, technological innovations, and lots more. The research report also offers an in-depth analysis of the Agreements, collaboration, and partnership among different merchants across the world.
Major Companies in the Market:
Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG, Biocon, VIVUS, Eli Lilly, Amgen, Zafgen, Roche, Eisai
Product Type segmentation:
Appetite Suppression, Increasing Body Metabolism, Interfering with the Digestion Absorption Patterns
Apart from that, the application market is segmented into:
Hospitals, Specialized Clinics, Retail Pharmacies, Mail Order Pharmacies, Others
You Can Ask For The Discount@ https://www.acquiremarketresearch.com/discount-request/348439/
By Geographical Regions:
North America (the U.S., Canada)
Latin America (Brazil, Mexico, Argentina, and other countries)
Asia Pacific (India, Japan, China, Australia, and New Zealand, and other countries)
Europe (Germany, France, the U.K., Spain, Italy, Russia, and other countries)
Middle East and Africa (GCC, South Africa, Israel, and Other countries)
Key Highlights of the Table of Contents:
Weight Loss Therapeutics Market Study Coverage: It includes market segments, key manufacturers covered, the scope of products offered within the years considered, Weight Loss Therapeutics Market and study objectives. Additionally, it touches on the segmentation study provided within the report on the idea of the sort of product and applications.
Weight Loss Therapeutics Market Executive summary: This section emphasizes the key studies, the market rate of growth, competitive landscape, market drivers, trends, and issues additionally to the macroscopic indicators.
Weight Loss Therapeutics Market Production by Region: The report delivers data associated with import and export, revenue, production, and key players of all regional markets studied are covered during this section
Weight Loss Therapeutics Market Profile of Manufacturers: Analysis of every market player profiled is detailed during this section.
Weight Loss Therapeutics Market
Buy Now Full Report Here @ https://www.acquiremarketresearch.com/buy-now/348439/price=su
TOC Of The Report :
Chapter 1. Report Overview
Chapter 2. Market Snapshot
2.1 Major Companies Overview
2.2 Weight Loss Therapeutics Market Concentration
2.3 Six-Year Compound Annual rate of growth (CAGR)
Chapter 3. Value Chain of Weight Loss Therapeutics Market
3.1 Upstream
3.2 Downstream
3.3 Porter’s & Five Forces Analysis
Chapter 4. Players Profiles
4.1 Company Profiles
4.2 introduction
4.3 Production, Revenue (2015-2020)
4.4 SWOT Analysis
Chapter 5. Global Weight Loss Therapeutics marketing research by Regions
5.1 Weight Loss Therapeutics Market Status and Prospect (2016-2025)
5.2 Weight Loss Therapeutics Market Size and rate of growth (2016-2025)
5.3 Weight Loss Therapeutics Market Local Capacity, Import, Export, Local Consumption Analysis.
Chapter 6. North America Weight Loss Therapeutics marketing research by Countries
Chapter 7. China Weight Loss Therapeutics marketing research by Countries
Chapter 8. Europe Weight Loss Therapeutics marketing research by Countries
Chapter 9. Asia-Pacific Weight Loss Therapeutics marketing research by Countries
Chapter 10. India Weight Loss Therapeutics marketing research by Countries
Chapter 11. Middle East and Africa Weight Loss Therapeutics marketing research by Countries
Chapter 12. South America Weight Loss Therapeutics marketing research by Countries
Chapter 13. Global Weight Loss Therapeutics Market Segment by Types
Chapter 14. Global Weight Loss Therapeutics Market Segment by Applications
Chapter 15. Weight Loss Therapeutics Market Forecast by Regions (2020-2025)
Chapter 16. Appendix
About Us:
Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose, and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.
Contact Us:
http://www.acquiremarketresearch.com/
#Weight Loss Therapeutics Market#Weight Loss Therapeutics Market Type#Weight Loss Therapeutics Outlook
0 notes
Text
Weight Loss Therapeutics Market Share, Analysis, Demand and Forecasts to 2025
The research report on Weight Loss Therapeutics market as well as industry is an in-depth study that provides detailed information of leading players, qualitative analysis and quantitative analysis, types & end-users; historical figures, region analysis, market technology landscape & restraints, strategic planning, and a precise section for the effect of Covid-19 on the industry. Our research analysts intensively determine the significant outlook of the global Weight Loss Therapeutics market study with regard to primary research & secondary research and they have represented it in the form of figures, pie charts, tables & other pictorial representations for better understanding.
To Know More Details About This Report, Get Sample @ http://www.acquiremarketresearch.com/sample-request/348439
The report on Weight Loss Therapeutics market claims this industry to emerge as one of the most lucrative spaces in the ensuing years, exhibiting a modest growth rate over the forecast period. Enumerating a highly exhaustive outline of Weight Loss Therapeutics Market size, this report is also inclusive of the total valuation that the Weight Loss Therapeutics industry presently holds, a brief segmentation of this market and Weight Loss Therapeutics market growth opportunities of this industry in addition to its geographical expanse.
Major Key Players Covered In This Report:
Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG, Biocon, VIVUS, Eli Lilly, Amgen, Zafgen, Roche, Eisai
Weight Loss Therapeutics Market Analysis by 2020
This research report based on ‘Weight Loss Therapeutics market’ and available with Acquire Market Research includes latest and upcoming market trends in addition to the global spectrum of the ‘Weight Loss Therapeutics market’ that includes numerous regions. Moreover, the research also expands on intricate details pertaining to contributions by key Manufacturers, import & export, demand and supply analysis as well as industry size, share growth of the Weight Loss Therapeutics industry.
The specified segments and sub-sections of the market are explained below:
By Product Type:
Appetite Suppression, Increasing Body Metabolism, Interfering with the Digestion Absorption Patterns
By Application/End-user:
Hospitals, Specialized Clinics, Retail Pharmacies, Mail Order Pharmacies, Others
By country/region:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Check Discount @ http://www.acquiremarketresearch.com/discount-request/348439
Frequently Asked Questions About This Market Research Report:
What are the latest trends, and strategies followed by leadings companies?
What is the market share of each Major Players specified in this report?
What are opportunities for Weight Loss Therapeutics investors and market aspirants?
What are the major product types and which applications are known?
Which countries are analyzed in this report?
What is the market size, and demand for Weight Loss Therapeutics on a global level?
What is the CAGR value of Weight Loss Therapeutics Market?
About Us:
Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.
Contact Us:
http://www.acquiremarketresearch.com/
0 notes
Text
Weight Loss Therapeutics Market Key Trends and Opportunities | 2020-2025
The research report on Weight Loss Therapeutics market as well as industry is an in-depth study that provides detailed information of leading players, qualitative analysis and quantitative analysis, types & end-users; historical figures, region analysis, market technology landscape & restraints, strategic planning, and a precise section for the effect of Covid-19 on the industry. Our research analysts intensively determine the significant outlook of the global Weight Loss Therapeutics market study with regard to primary research & secondary research and they have represented it in the form of figures, pie charts, tables & other pictorial representations for better understanding.
To Know More Details About This Report, Get Sample @ http://www.acquiremarketresearch.com/sample-request/347817
The report on Weight Loss Therapeutics market claims this industry to emerge as one of the most lucrative spaces in the ensuing years, exhibiting a modest growth rate over the forecast period. Enumerating a highly exhaustive outline of Weight Loss Therapeutics Market size, this report is also inclusive of the total valuation that the Weight Loss Therapeutics industry presently holds, a brief segmentation of this market and Weight Loss Therapeutics market growth opportunities of this industry in addition to its geographical expanse.
Major Key Players Covered In This Report:
Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG, Biocon, VIVUS, Eli Lilly, Amgen, Zafgen, Roche, Eisai
Weight Loss Therapeutics Market Analysis by 2020
This research report based on ‘Weight Loss Therapeutics market’ and available with Acquire Market Research includes latest and upcoming market trends in addition to the global spectrum of the ‘Weight Loss Therapeutics market’ that includes numerous regions. Moreover, the research also expands on intricate details pertaining to contributions by key Manufacturers, import & export, demand and supply analysis as well as industry size, share growth of the Weight Loss Therapeutics industry.
The specified segments and sub-sections of the market are explained below:
By Product Type:
Appetite Suppression, Increasing Body Metabolism, Interfering with the Digestion Absorption Patterns
By Application/End-user:
Hospitals, Specialized Clinics, Retail Pharmacies, Mail Order Pharmacies, Other
By country/region:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Check Discount @ http://www.acquiremarketresearch.com/discount-request/347817
Frequently Asked Questions About This Market Research Report:
What are the latest trends, and strategies followed by leadings companies?
What is the market share of each Major Players specified in this report?
What are opportunities for Weight Loss Therapeutics investors and market aspirants?
What are the major product types and which applications are known?
Which countries are analyzed in this report?
What is the market size, and demand for Weight Loss Therapeutics on a global level?
What is the CAGR value of Weight Loss Therapeutics Market?
About Us:
Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.
Contact Us:
http://www.acquiremarketresearch.com/
0 notes
Text
Global Weight Loss and Obesity Management Market Growth Is Driven By The Increasing Demands of Various Therapies and Geographical Regions- 2026
Global weight loss and obesity management market is expected to rise to an estimated value of USD 299.14 billion by 2026 registering a substantial CAGR of 6.70% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising pace of obesity and chronic diseases, technological advancements and the rising intake of junk food.
Obesity it is a medical condition when excessive accumulation and storage of fats happen within the body. It impacts the health of an individual in several ways, by increasing the likelihood of chronic diseases and thereby reducing the life expectancy of individuals. The weight loss and obesity management market would include all those equipment’s, diets, devices and drugs that would be utilized for controlling or reducing weight in obese individuals.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-weight-loss-and-obesity-management-market
Competitive Analysis: Global Weight Loss and Obesity Management Market
Global weight loss and obesity management market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of weight loss and obesity management market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Weight Loss and Obesity Management Market
Few of the major market competitors currently working in the weight loss and obesity management market are Ajinomoto Co.,Inc., Herbalife International of America, Inc., Nestlé SA, PepsiCo, Johnson Health Tech., THE COCA-COLA COMPANY, Nutrisystem, Inc., Mayo Foundation for Medical Education and Research (MFMER)., Zafgen, Inc., WW International, Inc., Jenny Craig, Diet Health, Inc., VLCC, 24 Hour Fitness USA, Inc., Life Time, Inc. Abbott., GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Atkins Nutritionals, Inc., Brunswick, Kellogg NA Co., Merck & Co., Inc., Reebok International., Unilever, Precor Incorporated., ALLERGAN, Johnson & Johnson Services, Inc., Decathlon, Technogym, Apollo Endosurgery, Inc., Amer Sports, GOLD'S GYM, among others.
Segmentation: Global Weight Loss and Obesity Management Market
By Diet (Meals, Beverages, Supplements)
By Equipment (Fitness, Surgical)
By Service (Fitness Centers and Health Clubs, Slimming Centers and Commercial Weight Loss Centers, Consulting Services, Online Weight Loss Programs)
By Service (Fitness Centers and Health Clubs, Slimming Centers and Commercial Weight Loss Centers, Consulting Services, Online Weight Loss Programs)
By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Market Drivers
The rising pace of obesity is creating the need for obesity management and weight loss programs
Increase in the technological advancement for treatment of obesity and weight loss
Increasing personal disposable income
Increasing number of chronic diseases
Rising intake of high-calorie junk food and beverages especially among children and women
The fast growth of the fast food industry is resulting in the adoption of unhealthy lifestyles
Reduction in the level of physical activities due to growing luxury, which reduce the need for movement
Increasing awareness about healthy lifestyle, and the benefits of remaining healthy
Increasing government initiatives in the form of programs launched to ensure health lifestyle of people contribute to the growth of this market
Introduction of new and innovative products to deal with obesity and weight loss problems.
For More Inquiry Contact us at: @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-weight-loss-and-obesity-management-market
Market Restraints
High cost of the obesity program, post obesity program
Harmful effects and complications of obesity programs hampers the growth of this market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Related Reports:
Global Stem Cell Therapy Market
#Weight Loss and Obesity Management Market#Weight Loss and Obesity Management#weight loss and obesity management market trends#Weight Loss and Obesity Management Market Industry#Weight Loss and Obesity Management Market News#Weight Loss and Obesity Management Market Research#Weight Loss and Obesity Management Market Analysis#Weight Loss and Obesity Management Market Size#Weight Loss and Obesity Management Market Share
0 notes
Text
Global Weight Loss and Obesity Management Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2026
Data Bridge Market Research has recently added a concise research on Global Weight Loss and Obesity Management Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. Some are the key & emerging players that are part of coverage and have being profiled are Life Time, Inc. Abbott., GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Atkins Nutritionals, Inc., Brunswick, Kellogg NA Co., Merck & Co., Inc., Reebok International., Unilever, Precor Incorporated., ALLERGAN, Johnson & Johnson Services, Inc., Decathlon, Technogym, Apollo Endosurgery, Inc., Amer Sports, GOLD'S GYM, among others.
Analysis of Global Weight Loss and Obesity Management Market report:
Global weight loss and obesity management market is expected to rise to an estimated value of USD 299.14 billion by 2026 registering a substantial CAGR of 6.70% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising pace of obesity and chronic diseases, technological advancements and the rising intake of junk food.
A FREE sample of this report is available upon request @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-weight-loss-and-obesity-management-market
Definition:
Obesity it is a medical condition when excessive accumulation and storage of fats happen within the body. It impacts the health of an individual in several ways, by increasing the likelihood of chronic diseases and thereby reducing the life expectancy of individuals. The weight loss and obesity management market would include all those equipment’s, diets, devices and drugs that would be utilized for controlling or reducing weight in obese individuals.
Market Drivers
· The rising pace of obesity is creating the need for obesity management and weight loss programs
· Increase in the technological advancement for treatment of obesity and weight loss
· Increasing personal disposable income
· Increasing number of chronic diseases
· Rising intake of high-calorie junk food and beverages especially among children and women
· The fast growth of the fast food industry is resulting in the adoption of unhealthy lifestyles
· Reduction in the level of physical activities due to growing luxury, which reduce the need for movement
· Increasing awareness about healthy lifestyle, and the benefits of remaining healthy
· Increasing government initiatives in the form of programs launched to ensure health lifestyle of people contribute to the growth of this market
· Introduction of new and innovative products to deal with obesity and weight loss problems.
Market Restraints
· High cost of the obesity program, post obesity program
· Harmful effects and complications of obesity programs hampers the growth of this market
Top Manufacturers Profiles Operating in the Global Weight Loss and Obesity Management Market:
Few of the major market competitors currently working in the weight loss and obesity management market are Ajinomoto Co.,Inc., Herbalife International of America, Inc., Nestlé SA, PepsiCo, Johnson Health Tech., THE COCA-COLA COMPANY, Nutrisystem, Inc., Mayo Foundation for Medical Education and Research (MFMER)., Zafgen, Inc., WW International, Inc., Jenny Craig, Diet Health, Inc., VLCC, 24 Hour Fitness USA, Inc., Life Time, Inc. Abbott., GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Atkins Nutritionals, Inc., Brunswick, Kellogg NA Co., Merck & Co., Inc., Reebok International., Unilever, Precor Incorporated., ALLERGAN, Johnson & Johnson Services, Inc., Decathlon, Technogym, Apollo Endosurgery, Inc., Amer Sports, GOLD'S GYM, among others.
Global Weight Loss and Obesity Management Market Segmentation:
· By Diet - (Meals, Beverages, Supplements)
· Equipment (Fitness, Surgical)
· Service (Fitness Centers and Health Clubs, Slimming Centers and Commercial Weight Loss Centers, Consulting Services, Online Weight Loss Programs)
· Service (Fitness Centers and Health Clubs, Slimming Centers and Commercial Weight Loss Centers, Consulting Services, Online Weight Loss Programs)
· Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Competitive Landscape:
Global weight loss and obesity management market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of weight loss and obesity management market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Make an Inquiry for Discount On this Report @
https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-weight-loss-and-obesity-management-market
Reasons to Purchase this Report
• Current and future of global dermatology drugs market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.
Contact:
Data Bridge Market Research
+1-888-387-2818
Find More Reports Related To This Category
Global Medical Exoskeleton Market
Global Microbiology Testing Market
#Global Weight Loss and Obesity Management Market#Global Weight Loss and Obesity Management Market trends#Global Weight Loss and Obesity Management Market applications#Global Weight Loss and Obesity Management Market size#Global Weight Loss and Obesity Management Market share
0 notes
Text
Anti-Obesity Drugs Market Analysis, Demand, Growth Opportunities and Recent Trends by Leading Manufacturers and Regions
The global anti-obesity drugs market is growing significantly, due to high prevalence of obesity and rich pipeline for anti-obesity drugs. The presence of large patient pool and massive unexplored market in the emerging economies, such as India and China, are creating ample opportunities for the growth of the global anti-obesity drugs market. The advanced research and development facilities, and new drug developments by the key players are propelling the demand for improved and cost-effective anti-obesity drugs, thus driving the growth of the global anti-obesity drugs market.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/anti-obesity-drugs-market/report-sample
Some of the factors driving the growth of the global anti-obesity drugs market are increasing awareness regarding obesity, growing healthcare expenditure, increasing geriatric population, increasing lifestyle related diseases, growing incidences of obesity and obesity related diseases. In addition, the major players are investing huge capital for the research and development of anti-obesity drugs; hence, fueling the growth of the global anti-obesity drugs market. However, stringent regulatory approvals, high cost of anti-obesity prescription drugs, and increasing patient compliance for surgical procedures are some of the factors, restraining the growth of the global anti-obesity drugs market to some extent.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=anti-obesity-drugs-market
Geographically, North America leads the global anti-obesity drugs market, due to high incidences of obesity, high healthcare expenditure, and increased awareness about obesity and obesity related risks among patients. In addition, the increasing involvement of government and non-government organizations to educate and aware people about the ill effects of obesity, and extensive research and development activities for the development of anti-obesity drugs are fueling the growth of the anti-obesity drugs market in North America. Asia-Pacific is the fastest growing region in the global anti-obesity drugs market. The fastest growth of the region is attributed to improving healthcare infrastructure, growing healthcare expenditure and increasing geriatric population. Moreover, the anti-obesity drugs market is growing due to increasing research and development facilities, growing disposable income, and presence of large patient pool in the emerging countries, such as India and China.
Some of the major players operating in the global anti-obesity drugs market are F. Hoffmann-La Roche AG, Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceuticals Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen, Rhythm Pharmaceuticals, Zydus Cadila, and Norgine B.V.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook
#anti-obesity drugs market#anti-obesity drugs market size#anti-obesity drugs market share#anti-obesity drugs market demand#anti-obesity drugs market growth#anti-obesity drugs market trends#anti-obesity drugs market analysis#anti-obesity drugs market research report
0 notes
Text
Breaking 52 Week High, Zafgen Inc (Nasdaq:ZFGN) Close At $12.04
Breaking 52 Week High, Zafgen Inc (Nasdaq:ZFGN) Close At $12.04
Zafgen Inc (Nasdaq:ZFGN)
September 27th, 2018
With markets going up Zafgen Inc closed Thursday up 0.42%, a $0.05 increase to close on $12.04. Furthermore it hit a new 52 week high of $12.36. The stock continues to trade well at 262% of its 52 week low of $3.33. (more…)
View On WordPress
#Communication Services#Consumer Discretionary#Consumer Staples#Energy#finance#Financial Sector#Financials#Healthcare#Industrials#Information Technology#Materials#news#Real Estate#Utilities#Zafgen Inc#ZFGN
0 notes